Literature DB >> 30242958

Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.

Anna Florczak1,2,3, Katarzyna Jastrzebska1,2,3, Wojciech Bialas4, Andrzej Mackiewicz1,3, Hanna Dams-Kozlowska1,3.   

Abstract

Bioengineered spider silk is a focus of research due to its biocompatibility, biodegradability, and excellent mechanical properties. Functionalized silk can be processed into spheres and employed as selective drug delivery vehicles in targeted cancer treatment. Efficient, repeatable and controllable processing conditions are essential to drug carrier development. This study aimed to optimize the processing conditions of silk spheres formation, scale-up, and automation of the silk spheres production process. The automated micromixing system provided substantial amounts of silk spheres under repetitive production conditions. Micromixing resulted in smaller sphere sizes and narrower sphere size distributions than mixing with a pipette. Furthermore, the particle size and size distribution of silk spheres could be tailored by varying mixing process parameters, such as protein concentration, silk and salting out buffer ratio, mixing speed, and the size of the tubes and mixing zone. In addition, the implementation of ultrafiltration techniques provided a fast and efficient concentration of spheres in water. Furthermore, the shear forces introduced by micromixing did not impede the properties of the Her2 binding peptide (H2.1) since the functionalized H2.1MS1:H2.1MS2 silk spheres selectively were internalized by Her2-positive cancer cells. This study indicated that micromixing in combination with ultrafiltration enabled scale-up of the sphere production process under controllable and repeatable conditions.
© 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 3211-3221, 2018. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer therapy; drug carrier; micromixing; protein bioengineering; silk; spheres; targeted drug delivery

Mesh:

Substances:

Year:  2018        PMID: 30242958     DOI: 10.1002/jbm.a.36516

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  4 in total

1.  Manual Versus Microfluidic-Assisted Nanoparticle Manufacture: Impact of Silk Fibroin Stock on Nanoparticle Characteristics.

Authors:  Jana I Solomun; John D Totten; Thidarat Wongpinyochit; Alastair J Florence; F Philipp Seib
Journal:  ACS Biomater Sci Eng       Date:  2020-04-20

2.  Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.

Authors:  Anna Florczak; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Journal:  Int J Nanomedicine       Date:  2019-08-26

3.  Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.

Authors:  Anna Florczak; Tomasz Deptuch; Anna Lewandowska; Karolina Penderecka; Elzbieta Kramer; Andrzej Marszalek; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Journal:  J Nanobiotechnology       Date:  2020-12-01       Impact factor: 10.435

4.  In vivo study of the immune response to bioengineered spider silk spheres.

Authors:  Tomasz Deptuch; Karolina Penderecka; Mariusz Kaczmarek; Sara Molenda; Hanna Dams-Kozlowska
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.